7-phenylethylamino-4H-pyrimido4,5-d1,3oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors

摘要

A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and having the structure: (I).;